LN-643914
Lesinurad Impurity N , 0.97 , 1533519-99-1
Update time: 2023-04-23
PRODUCT Properties
Density | 1.56±0.1 g/cm3(Predicted) |
pka | 2.97±0.10(Predicted) |
Description and Uses
4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.